Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease

Michael J. Reiter, Arthur R. Easley, David E. Mann

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The effects of lidocaine, tocainide and mexiletine were examined in 17 patients with coronary artery disease and chronic, recurrent, sustained ventricular tachycardia (VT) or ventricular fibrillation and inducible VT. Eleven patients presented with sustained VT; 6 patients had had an episode of sudden death from which they had been resuscitated. All patients were refractory to conventional antiarrhythmic agents. Lidocaine prevented induction of VT in only 3 patients (18%). Tocainide prevented induction of VT in only 1 lidocaine-responsive patient. Mexiletine prevented VT induction in 1 patient who had responded to lidocaine but not tocainide. Neither tocainide nor mexiletine was effective in preventing induction of VT in any patient who did not respond to lidocaine. Lidocaine terminated VT in 3 patients, but this did not predict noninducibility with lidocaine, tocainide or mexiletine. Cycle length of VT was prolonged slightly by lidocaine (control 311 ± 14 ms, lidocaine 361 ± 26 ms, p < 0.05), tocainide (344 ± 16 ms, p < 0.05) and mexiletine (371 ± 27 ms, mean ± standard error of the mean, p < 0.05). Thus, class lb agents are infrequently effective in preventing induction of VT in this group of patients, electrophysiologic inefficacy of lidocaine is highly predictive of continued inducibility with tocainide and mexiletine, and termination of VT with lidocaine does not correlate with its ability to prevent VT induction.

Original languageEnglish (US)
Pages (from-to)1319-1324
Number of pages6
JournalThe American Journal of Cardiology
Volume59
Issue number15
DOIs
StatePublished - Jun 1 1987

Fingerprint

Ventricular Tachycardia
Lidocaine
Tocainide
Coronary Artery Disease
Mexiletine
Ventricular Fibrillation
Sudden Death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. / Reiter, Michael J.; Easley, Arthur R.; Mann, David E.

In: The American Journal of Cardiology, Vol. 59, No. 15, 01.06.1987, p. 1319-1324.

Research output: Contribution to journalArticle

@article{a06913d221904e929f76bd87ad2d8a63,
title = "Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease",
abstract = "The effects of lidocaine, tocainide and mexiletine were examined in 17 patients with coronary artery disease and chronic, recurrent, sustained ventricular tachycardia (VT) or ventricular fibrillation and inducible VT. Eleven patients presented with sustained VT; 6 patients had had an episode of sudden death from which they had been resuscitated. All patients were refractory to conventional antiarrhythmic agents. Lidocaine prevented induction of VT in only 3 patients (18{\%}). Tocainide prevented induction of VT in only 1 lidocaine-responsive patient. Mexiletine prevented VT induction in 1 patient who had responded to lidocaine but not tocainide. Neither tocainide nor mexiletine was effective in preventing induction of VT in any patient who did not respond to lidocaine. Lidocaine terminated VT in 3 patients, but this did not predict noninducibility with lidocaine, tocainide or mexiletine. Cycle length of VT was prolonged slightly by lidocaine (control 311 ± 14 ms, lidocaine 361 ± 26 ms, p < 0.05), tocainide (344 ± 16 ms, p < 0.05) and mexiletine (371 ± 27 ms, mean ± standard error of the mean, p < 0.05). Thus, class lb agents are infrequently effective in preventing induction of VT in this group of patients, electrophysiologic inefficacy of lidocaine is highly predictive of continued inducibility with tocainide and mexiletine, and termination of VT with lidocaine does not correlate with its ability to prevent VT induction.",
author = "Reiter, {Michael J.} and Easley, {Arthur R.} and Mann, {David E.}",
year = "1987",
month = "6",
day = "1",
doi = "10.1016/0002-9149(87)90912-X",
language = "English (US)",
volume = "59",
pages = "1319--1324",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "15",

}

TY - JOUR

T1 - Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease

AU - Reiter, Michael J.

AU - Easley, Arthur R.

AU - Mann, David E.

PY - 1987/6/1

Y1 - 1987/6/1

N2 - The effects of lidocaine, tocainide and mexiletine were examined in 17 patients with coronary artery disease and chronic, recurrent, sustained ventricular tachycardia (VT) or ventricular fibrillation and inducible VT. Eleven patients presented with sustained VT; 6 patients had had an episode of sudden death from which they had been resuscitated. All patients were refractory to conventional antiarrhythmic agents. Lidocaine prevented induction of VT in only 3 patients (18%). Tocainide prevented induction of VT in only 1 lidocaine-responsive patient. Mexiletine prevented VT induction in 1 patient who had responded to lidocaine but not tocainide. Neither tocainide nor mexiletine was effective in preventing induction of VT in any patient who did not respond to lidocaine. Lidocaine terminated VT in 3 patients, but this did not predict noninducibility with lidocaine, tocainide or mexiletine. Cycle length of VT was prolonged slightly by lidocaine (control 311 ± 14 ms, lidocaine 361 ± 26 ms, p < 0.05), tocainide (344 ± 16 ms, p < 0.05) and mexiletine (371 ± 27 ms, mean ± standard error of the mean, p < 0.05). Thus, class lb agents are infrequently effective in preventing induction of VT in this group of patients, electrophysiologic inefficacy of lidocaine is highly predictive of continued inducibility with tocainide and mexiletine, and termination of VT with lidocaine does not correlate with its ability to prevent VT induction.

AB - The effects of lidocaine, tocainide and mexiletine were examined in 17 patients with coronary artery disease and chronic, recurrent, sustained ventricular tachycardia (VT) or ventricular fibrillation and inducible VT. Eleven patients presented with sustained VT; 6 patients had had an episode of sudden death from which they had been resuscitated. All patients were refractory to conventional antiarrhythmic agents. Lidocaine prevented induction of VT in only 3 patients (18%). Tocainide prevented induction of VT in only 1 lidocaine-responsive patient. Mexiletine prevented VT induction in 1 patient who had responded to lidocaine but not tocainide. Neither tocainide nor mexiletine was effective in preventing induction of VT in any patient who did not respond to lidocaine. Lidocaine terminated VT in 3 patients, but this did not predict noninducibility with lidocaine, tocainide or mexiletine. Cycle length of VT was prolonged slightly by lidocaine (control 311 ± 14 ms, lidocaine 361 ± 26 ms, p < 0.05), tocainide (344 ± 16 ms, p < 0.05) and mexiletine (371 ± 27 ms, mean ± standard error of the mean, p < 0.05). Thus, class lb agents are infrequently effective in preventing induction of VT in this group of patients, electrophysiologic inefficacy of lidocaine is highly predictive of continued inducibility with tocainide and mexiletine, and termination of VT with lidocaine does not correlate with its ability to prevent VT induction.

UR - http://www.scopus.com/inward/record.url?scp=0023223361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023223361&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(87)90912-X

DO - 10.1016/0002-9149(87)90912-X

M3 - Article

C2 - 3109228

AN - SCOPUS:0023223361

VL - 59

SP - 1319

EP - 1324

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 15

ER -